Company intelligence / Profile preview

Alpha Preclinical

Massachusetts, United Statesalphapreclinical.com ↗

Ownership: Private
Development stage: Other

Overview

Alpha Preclinical is a discovery-focused preclinical research service company that partners with pharmaceutical, biotech companies, and research institutions to provide customized studies supporting drug development. They offer expertise in PK/PD studies, gene therapy, autoimmune diseases, metabolic diseases, inflammation/fibrosis models, and tumor models. The company emphasizes trust, innovation, transparency, and customer-centricity in its operations.

Therapeutic areas: Metabolic DisordersOncologyImmunology
Modalities: Small moleculeGene therapyBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Alpha Preclinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha Preclinical.

Explore the full profile